Scholarlink

<p>Fibromyalgia (FM) is frequently observed in patients with psoriatic arthritis (PsA) and can contribute to reduced quality of life (QoL) and potentially unnecessary treatment escalation. Cultural factors may influence the presentation and impact of FM. To determine the prevalence of FM in patients with PsA using the Fibromyalgia Rapid Screening Tool (FiRST), identify associated clinical factors, and assess agreement between FiRST results and physician-reported FM based on clinical opinion. post-hoc, cross-sectional study of the multicounty TACTIC dataset across 13 Arab countries. FM was defined by a FiRST ≥ 5. We compared Disease activity (DAPSA), Physician Global Assessment (PhGA), and validated patient-reported outcomes (PROs), and fitted a multivariable logistic model to identify predictors. Agreement between FiRST and physician-reported FM was assessed using the Intraclass Correlation Coefficient (ICC), diagnostic discrimination of FiRST against physician reported FM was evaluated by ROC/AUC. Among 536 PsA patients, 19.0% screened positive for FM (FiRST ≥ 5). In multivariable analysis, higher BMI, dyslipidemia, non-oligoarticular pattern, lower ESR, higher DAPSA, and higher PHQ-4 were independently associated with FM. Agreement between FiRST and physician-reported FM status was moderate (ICC 0.59; 95% CI 0.51–0.66), and FiRST discrimination for physician diagnosis was excellent (AUC = 0.833, 95% CI 0.793–0.873). Approximately 1 in 5 patients with PsA in Arab countries screened positive for FM. FM was associated with higher disease activity and PRO burden despite lower ESR. Findings support routine FM screening in PsA, particularly when PROs are high but inflammatory markers are low, to ensure assessment and holistic management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of concomitant fibromyalgia on patient-reported outcomes and inflammatory markers in psoriatic arthritis: a multinational cross-sectional study

  • 期刊论文

  • 发表日期：

    2025年12月8日

查看全文
  • Avin Maroof,
  • Nelly Ziadé,
  • Noura Abbas,
  • Laure Gossec,
  • Lina El Kibbi,
  • Bassel Elzorkany,
  • Nizar Abdulateef Jassim,
  • Faiq I. Gorial,
  • Asal Adnan,
  • Nada Al Shamaa,
  • Chafika Haouichat,
  • Fatima Alnaimat,
  • Suad Hannawi,
  • Saed Atawnah,
  • Sahar A. Saad,
  • Hussein Halabi,
  • Laila Aljazwi,
  • Basel K. Masri,
  • Ahmed Abogamal,
  • Laila Ayoub,
  • Bahiri Rachid,
  • Krystel Aouad,
  • Ihsane Hmamouchi,
  • Manal Al Mashaleh

摘要

Fibromyalgia (FM) is frequently observed in patients with psoriatic arthritis (PsA) and can contribute to reduced quality of life (QoL) and potentially unnecessary treatment escalation. Cultural factors may influence the presentation and impact of FM. To determine the prevalence of FM in patients with PsA using the Fibromyalgia Rapid Screening Tool (FiRST), identify associated clinical factors, and assess agreement between FiRST results and physician-reported FM based on clinical opinion. post-hoc, cross-sectional study of the multicounty TACTIC dataset across 13 Arab countries. FM was defined by a FiRST ≥ 5. We compared Disease activity (DAPSA), Physician Global Assessment (PhGA), and validated patient-reported outcomes (PROs), and fitted a multivariable logistic model to identify predictors. Agreement between FiRST and physician-reported FM was assessed using the Intraclass Correlation Coefficient (ICC), diagnostic discrimination of FiRST against physician reported FM was evaluated by ROC/AUC. Among 536 PsA patients, 19.0% screened positive for FM (FiRST ≥ 5). In multivariable analysis, higher BMI, dyslipidemia, non-oligoarticular pattern, lower ESR, higher DAPSA, and higher PHQ-4 were independently associated with FM. Agreement between FiRST and physician-reported FM status was moderate (ICC 0.59; 95% CI 0.51–0.66), and FiRST discrimination for physician diagnosis was excellent (AUC = 0.833, 95% CI 0.793–0.873). Approximately 1 in 5 patients with PsA in Arab countries screened positive for FM. FM was associated with higher disease activity and PRO burden despite lower ESR. Findings support routine FM screening in PsA, particularly when PROs are high but inflammatory markers are low, to ensure assessment and holistic management.